CINECA IRIS Institutional Research Information System

FORNAI, MATTEO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 9.726
EU - Europa 4.864
AS - Asia 1.668
AF - Africa 247
SA - Sud America 23
OC - Oceania 13
Continente sconosciuto - Info sul continente non disponibili 3
Totale 16.544
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 9.498
IT - Italia 2.160
SE - Svezia 825
CN - Cina 669
BG - Bulgaria 423
DE - Germania 378
SG - Singapore 339
GB - Regno Unito 262
VN - Vietnam 228
CA - Canada 214
AT - Austria 193
TR - Turchia 158
CI - Costa d'Avorio 150
FI - Finlandia 140
UA - Ucraina 135
RU - Federazione Russa 94
HK - Hong Kong 93
IN - India 83
FR - Francia 64
CH - Svizzera 49
SN - Senegal 47
PL - Polonia 44
BE - Belgio 40
NG - Nigeria 32
IR - Iran 25
PK - Pakistan 16
JP - Giappone 14
MX - Messico 13
CZ - Repubblica Ceca 12
KR - Corea 12
BR - Brasile 11
NL - Olanda 11
AU - Australia 8
BJ - Benin 7
ES - Italia 7
CL - Cile 5
EC - Ecuador 5
IE - Irlanda 5
NO - Norvegia 5
NZ - Nuova Zelanda 5
ID - Indonesia 4
UZ - Uzbekistan 4
EU - Europa 3
GH - Ghana 3
HU - Ungheria 3
IQ - Iraq 3
LB - Libano 3
PH - Filippine 3
PT - Portogallo 3
RO - Romania 3
TW - Taiwan 3
AE - Emirati Arabi Uniti 2
AZ - Azerbaigian 2
DK - Danimarca 2
MA - Marocco 2
RS - Serbia 2
UG - Uganda 2
BD - Bangladesh 1
BN - Brunei Darussalam 1
CM - Camerun 1
CO - Colombia 1
CU - Cuba 1
DZ - Algeria 1
GR - Grecia 1
IL - Israele 1
JO - Giordania 1
LV - Lettonia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
OM - Oman 1
PE - Perù 1
SI - Slovenia 1
TH - Thailandia 1
TN - Tunisia 1
ZA - Sudafrica 1
Totale 16.544
Salva come PNG Salva come JPEG
Città #
Woodbridge 1.125
Fairfield 1.107
Ann Arbor 959
Houston 847
Chandler 828
Ashburn 572
Milan 478
Seattle 439
Wilmington 424
Sofia 423
Cambridge 387
Serra 382
Beijing 270
New York 251
Boardman 224
Ottawa 195
Princeton 185
Jacksonville 161
Lawrence 161
Singapore 152
Abidjan 150
Izmir 145
Vienna 142
Medford 140
Pisa 133
Dong Ket 112
Florence 112
Nanjing 108
Des Moines 103
Hong Kong 83
Rome 82
Bremen 76
London 75
Dearborn 62
Chicago 60
Nanchang 54
Dakar 47
Ogden 45
Lancaster 44
Falls Church 42
Bern 40
San Diego 40
Brussels 38
Frankfurt am Main 38
Dallas 37
Redwood City 37
Lagos 32
Lappeenranta 32
Pune 30
Jüchen 29
Los Angeles 29
Marseille 27
Hebei 26
Washington 26
Boulder 25
Warsaw 25
Kunming 20
Norwalk 19
Tianjin 19
Kent 18
Livorno 17
Auburn Hills 16
Changsha 16
Jiaxing 15
Pistoia 15
Padova 14
Naples 13
Palermo 13
Shenyang 13
Detroit 12
Hefei 12
Lucca 12
Phoenix 12
Hangzhou 11
Nürnberg 11
Turin 11
Brno 10
Guangzhou 10
Bologna 9
Munich 9
Parma 9
Shanghai 9
Toronto 9
Verona 9
Ancona 8
Omaha 8
Redmond 8
Aguascalientes 7
Brescia 7
Cotonou 7
Council Bluffs 7
Fremont 7
Helsinki 7
Montecatini Terme 7
Tappahannock 7
Bari 6
Molise 6
Sargodha 6
Bergen 5
Cagliari 5
Totale 12.367
Salva come PNG Salva come JPEG
Nome #
Derivati isoindolici come attivatori di AMPK 370
An integrated assessment of histopathological changes of the enteric neuromuscular compartment in experimental colitis. 185
Preparation of isoindoline derivatives for use as AMPK activators 184
Exploiting the Pyrazolo[3,4-d]pyrimidin-4-one ring system as a useful template to obtain potent adenosine deaminase inhibitors, 181
Protective Role of Flavonoids Against Colonic Motor Dysfunctions Associated with High Fat Diet-Induced Obesity 178
COMPOSTI INIBITORI DELL’INFLAMMASOMA NLRP3 E LORO USO 174
Derivati benzofuranici come attivatori di AMPK 170
Anti-inflammatory effect of a novel adenosine deaminase inhibitor in experimental colitis 166
Resistance artery mechanics and composition in angiotensin II-infused mice: effects of cyclooxygenase-1 inhibition 147
A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis 147
Quality of adverse drug reaction (QADRA) reports: an algorithm to appraise the efficiency of spontaneous reporting systems in pharmacovigilance 146
Pathophysiology of NSAID-associated intestinal lesions in the rat: Luminal bacteria and mucosal inflammation as targets for prevention 146
Safety of MF-59 adjuvanted vaccine for pandemic influenza: results of the vaccination campaign in an Italian health district 142
Influence of the serotonin transporter 5HTTLPR polymorphism on symptom severity in irritable bowel syndrome 140
Constitutive expression of cyclooxygenase-2 in the neuromuscular compartment of normal human colon 139
Small bowel protection against NSAID-injury in rats: Effect of rifaximin, a poorly absorbed, GI targeted, antibiotic 137
Endothelial dysfunction in small arteries of essential hypertensive patients: role of cyclooxygenase-2 in oxidative stress generation 136
NSAID-induced enteropathy: are the currently available selective COX-2 inhibitors all the same? 134
Colonic dysmotility associated with high-fat diet-induced obesity: Role of enteric glia 133
Alteration of colonic excitatory tachykininergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 132
Colonic motor dysfunctions in a mouse model of high-fat diet-induced obesity: an involvement of A2B adenosine receptors 132
Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation 130
Enteric protective effects of the combination Bifidobacterium longum and lactoferrin in a rat model of diclofenac-induced intestinal injury. 129
Emerging role of Cyclooxygenase isoforms in the control of gastrointestinal neuromuscular functions 129
Canonical and Non-Canonical Activation of NLRP3 Inflammasome at the Crossroad between Immune Tolerance and Intestinal Inflammation 127
The AMPK enzyme-complex: from the regulation of cellular energy homeostasis to a possible new molecular target in the management of chronic inflammatory disorders 124
Expression pattern of COX isoforms in experimental models of enteric and airway inflammation 123
The blockade of adenosine deaminase ameliorates chronic experimental colitis through the recruitment of adenosine A2A and A3 receptors 123
Allopurinol adherence among patients with gout: an Italian general practice database study 123
Adverse reactions to oncologic drugs: spontaneous reporting and signal detection 123
Role of cyclooxygenase isoforms in the altered excitatory motor pathways of human colon with diverticular disease 123
Adenosine and inflammation: what's new on the horizon? 122
Neuropsychiatric adverse events associated with statins: epidemiology, pathophysiology, prevention and management 121
Genetics and pharmacogenetics of aminergic transmitter pathways in functional gastrointestinal disorders 121
The flavonoid compound apigenin prevents colonic inflammation and motor dysfunctions associated with high fat diet-induced obesity 121
Switching off CD73: a way to boost the activity of conventional and targeted antineoplastic therapies 121
Effects of esomeprazole on healing of non-steroidal anti-inflammatory drug (NSAID)-induced gastric ulcers in the presence of a continued NSAID treatment: characterization of molecular mechanisms 120
Lansoprazole prevents experimental gastric injury induced by non-steroidal anti-inflammatory drugs through a reduction of mucosal oxidative damage 119
Adenosine deaminase in the modulation of immune system and its potential as a novel target for treatment of inflammatory disorders 119
A Comparative Study on the Efficacy of NLRP3 Inflammasome Signaling Inhibitors in a Pre-clinical Model of Bowel Inflammation 119
Safety concerns associated with the use of serotonin reuptake inhibitors and other serotonergic/noradrenergic antidepressants during pregnancy: a review 117
Telogen effluvium following bivalent human papilloma virus vaccine administration: a report of two cases 117
Clinical evaluation of piroxicam-FDDF and azithromycin in the prevention of complications associated with impacted lower third molar extraction 117
Response to Endothelial nitric oxide synthase, cyclooxygenase-2, and essential hypertension: is there an interaction? 117
Involvement of the P2X7 purinergic receptor in colonic motor dysfunction associated with bowel inflammation in rats 117
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 116
Transient acute liver failure complicating transurethral resection syndrome 116
Enteric dysfunctions in experimental Parkinson's disease: alterations of excitatory cholinergic neurotransmission regulating colonic motility in rats 116
Assessment of serum cytokines predicts clinical and endoscopic outcomes to vedolizumab in ulcerative colitis patients 116
The role of purinergic pathways in the pathophysiology of gut diseases: pharmacological modulation and potential therapeutic applications 113
Control of enteric neuromuscular functions by purinergic A3 receptors in normal rat distal colon and experimental bowel inflammation 112
Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases 112
Nonsteroidal anti-inflammatory drug-activated gene-1 plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer healing 112
Neuromodulation of colonic motility by cycloxygenase isoforms in the presence of experimental bowel inflammation 111
Cholecystokinin CCK2 receptors mediate the peptide's inhibitory actions on the contractile activity of human distal colon via the nitric oxide pathway 111
Cyclooxygenase inhibitors modulate pro-fibrotic signalling mediated by TGFbeta in experimental colitis 110
Microbiota-gut-brain axis in health and disease: Is NLRP3 inflammasome at the crossroads of microbiota-gut-brain communications? 110
Mild hypothyroidism anticipates and accelerates age-related endothelial dysfunction in rat mesenteric small arteries: role of inducibile NO synthase 109
Role of A2a adenosine in the regulation of colonic motility in normal human colon 108
Cyclooxygenase-1 is involved in endothelial dysfunction of mesenteric small arteries from angiotensin II-infused mice 108
Adenosine pathway and cancer: where do we go from here? 108
Adenosine regulation of the immune system 108
A1 and A2a receptors mediate inhibitory rffects of adenosine on the motor activity of human colon 106
Inducible Nitric Oxide Synthase is involved in endothelial dysfunction of mesenteric small arteries from hypothyroid rats 106
Quantitative and qualitative changes of colonic myenteric ganglia in patients with ulcerative colitis 105
NSAID activated gene (NAG-1) plays a role in the impairing effects of cyclooxygenase inhibitors on gastric ulcer repair 105
CCK2 receptors mediate inhibitory effects of cholecystokinin on the motor activity of guinea-pig distal colon 105
Development of an Acrylate Derivative Targeting the NLRP3 Inflammasome for the Treatment of Inflammatory Bowel Disease 105
AMPK Activators as Novel Drug Candidates for the Treatment of Inflammatory Bowel Diseases 105
High Levels of β-Amyloid, Tau, and Phospho-Tau in Red Blood Cells as Biomarkers of Neuropathology in Senescence-Accelerated Mouse 105
Protective effects of the combination Bifidobacterium longum plus lactoferrin against NSAID-induced enteropathy 105
A holistic view of adenosine pathways in the control of intestinal neuromuscular functions: the enteric purinome concept 104
Intestinal dysfunction in Parkinson's disease: Lessons learned from translational studies and experimental models 104
Effects of selective cyclooxygenase-2 inhibitors on healing of experimental gastric ulcers and mucosal expression of cyclooxygenase isoforms 103
Differential recruitment of high affinity A1 and A2A adenosine receptors in the control of colonic neuromuscular function in experimental colitis 103
Mechanisms underlying the non-anticoagulant effects of apixaban and dabigatran on the integrity of intestinal mucosa: a comparative pre-clinical study. 103
Neonatal Adaptation Issues After Maternal Exposure to Prescription Drugs: Withdrawal Syndromes and Residual Pharmacological Effects 103
Effects of L-DOPA/benserazide co-treatment on colonic excitatory cholinergic motility and enteric inflammation following dopaminergic nigrostriatal neurodegeneration 103
Efficay and tolerability of meloxicam, a COX-2 preferential nonsteroidal anti-inflammatory drug: a review 102
Role of coxibs in the strategies for gastrointestinal protection in patients requiring chronic non-steroidal anti-inflammatory therapy 101
Clinical efficacy of esomeprazole in the prevention and healing of digestive toxicity associated with non-steroidal anti-inflammatory drugs in elderly patients 101
Reduced modulating actions of adenosine pathways on enteric neuromuscular activity in experimental colitis 100
Cyclooxygenase-2 inhibition improves vascular endothelial dysfunction in a rat model of endotoxic shock: role of iNOS and oxidative stress 100
Interplay among gut microbiota, intestinal mucosal barrier and enteric neuro-immune system: a common path to neurodegenerative diseases? 100
Differential role of A1 and A2a purinergic receptors in the control of colonic neurumuscular function in the presence of experimental colitis 99
Drug-induced taste and smell alterations: a case/non-case evaluation of an Italian database of spontaneous adverse drug reaction reporting 99
Preparation of benzofuran derivatives for use as AMPK activators 99
Prodromal Intestinal Events in Alzheimer's Disease (AD): Colonic Dysmotility and Inflammation Are Associated with Enteric AD-Related Protein Deposition 98
The administration of Enterococcus faecium SF68 counteracts compositional shifts in the gut microbiota of diet-induced obese mice 96
Risankizumab for the treatment of moderate to severe psoriasis 96
Serum oncostatin M at baseline predicts mucosal healing in Crohn's disease patients treated with infliximab 96
Luteolin Prevents Cardiometabolic Alterations and Vascular Dysfunction in Mice With HFD-Induced Obesity 95
Effects of a bicarbonate-alkaline mineral water on digestive motility in experimental models of functional and inflammatory gastrointestinal disorders 94
Inhibition of adenosine deaminase attenuates inflammation in experimental colitis 93
Cycloxygenases 1 and 2 expression in neuromuscular compartment of normal human colon 92
Dietary flavonoids as a potential intervention to improve redox balance in obesity and related co-morbidities: a review 92
Role of cyclooxygenases 1 and 2 in the modulation of neuromuscular functions in the distal colon of humans and mice 92
Glial A2B Adenosine Receptors Modulate Abnormal Tachykininergic Responses and Prevent Enteric Inflammation Associated with High Fat Diet-Induced Obesity 92
Effects of proton pump inhibitors on healing of gastric ulcerations induced by a continued non steroidal anti-inflammatory drug (NSAID) treatment 91
Characterization of mechanisms underlying the effects of esomeprazole on the impairment of gastric ulcer healing with addition of NSAID treatment 91
Totale 12.026
Salva come PNG Salva come JPEG
Categoria #
all - tutte 51.962
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 51.962
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20202.245 0 0 0 202 284 301 316 264 325 195 286 72
2020/20211.643 136 106 120 82 123 80 70 124 216 189 86 311
2021/20222.001 36 97 62 114 377 282 79 118 109 84 138 505
2022/20232.936 321 388 210 291 299 371 34 239 507 49 195 32
2023/20242.541 245 254 302 198 385 408 64 111 104 94 125 251
2024/2025475 72 247 112 44 0 0 0 0 0 0 0 0
Totale 17.209